New drug combo trial aims to control advanced stomach cancer
Disease control
Not yet recruiting
This study is testing whether adding an experimental drug called KQB198 to the standard treatment imatinib is safe and more effective for people with advanced gastrointestinal stromal tumors (GIST). It will involve about 46 patients who are starting their first treatment for canc…
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC